Answers are grounded in this paper and cite their sources.
Background: Allergic nasal polyposis is a chronic inflammatory condition commonly associated with type 2 immune responses and elevated cytokines, particularly interleukin-13 (IL-13). Identifying reliable biomarkers may improve diagnosis and disease characterization. Objective: To evaluate serum and nasal IL-13 levels in patients with allergic nasal polyps and assess their diagnostic accuracy and association with clinical features and disease severity. Methods: This case–control study was conducted on 53 patients with allergic nasal polyps and 53 matched healthy controls. All participants underwent clinical assessment, nasal symptom scoring, endoscopic examination, and CT of the paranasal sinuses. Serum and nasal lavage IL-13 levels were measured using ELISA. Laboratory parameters were analyzed, and correlations between IL-13 levels, clinical symptoms, and polyp grade were evaluated. Results: Patients with allergic nasal polyps showed significantly higher nasal symptom scores, eosinophil counts, and serum and nasal IL-13 levels compared with controls (p < 0.05). Nasal IL-13 demonstrated superior diagnostic performance (AUC = 0.897, sensitivity 92.4%, specificity 85.9%) compared with serum IL-13 (AUC = 0.789). Serum IL-13 showed a positive correlation with neutrophil count and negative correlations with symptom scores, hemoglobin, and eosinophils, while nasal IL-13 correlated positively with symptom severity and hemoglobin. No significant association was found between IL-13 levels and polyp grade. Conclusion: Both serum and nasal IL-13 are reliable biomarkers for detecting allergic nasal polyps, with nasal IL-13 offering higher diagnostic accuracy. Larger multicenter studies are needed to validate these findings and explore additional inflammatory biomarkers.
No takes yet. Share an insight, caveat, or question.
Mizar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: